loading...| Preferred Name | daunorubicinol | |
| Synonyms |
dihydrodaunomycin 7,8,9,10-tetrahydro-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxohexopyranosyl)oxy)-8-(1-hydroxyethyl)-1-methoxy-6,8,11-trihydroxy-5,12-Naphthacenedione duborimycin leukaemomycin D 13-dihydrodaunorubicin daunomycinol daunorubicinol hydrochloride |
|
| ID |
http://purl.bioontology.org/ontology/MESH/C000847 |
|
| altLabel |
dihydrodaunomycin 7,8,9,10-tetrahydro-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxohexopyranosyl)oxy)-8-(1-hydroxyethyl)-1-methoxy-6,8,11-trihydroxy-5,12-Naphthacenedione duborimycin leukaemomycin D 13-dihydrodaunorubicin daunomycinol daunorubicinol hydrochloride |
|
| cui |
C0057159 C0969848 |
|
| Has mapping qualifier | ||
| HM |
D003630/Q000031 |
|
| Inverse of RB |
28008-53-9 YDU8YIP30L |
|
| Mapped to | ||
| MDA |
19710101 |
|
| MeSH Frequency |
72 |
|
| MMR |
20150817 |
|
| notation |
C000847 |
|
| PI |
*AMINOGLYCOSIDES (74-75) *NAPHTHACENES (71-75) GLYCOSIDES (71-74) |
|
| prefLabel |
daunorubicinol |
|
| RR |
28008-53-9 28008-55-1 (daunorubicinol) |
|
| SC |
1 |
|
| Scope Statement |
main metabolite of daunomycin |
|
| SRC |
Bull Cancer 65(2):8;1978 Nouve Presse Med 7(3):2658;1978 J Antibiot (Tokyo) 30(5):425;1977 J Chromatogr 125(1):369;1976 J Chromatogr 153:211;1978 J Chromatogr 149:225;1978 Biochem Biophys Res Commun 84(2):441;1978 Biomed 29(5):164;1978 Bull Cancer 63(1):41;1976 |
|
| TERMUI |
T070805 T070803 T070806 T070808 T070804 T070807 T337481 |
|
| TH |
NLM (1971) INN (19XX) FDA SRS (2015) |
|
| tui |
T109 T195 T121 |